Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Endocrine disorders

Get Updates

Endocrine disorders research articles, Endocrine disorders research article, Endocrine disorders journals, Endocrine disorders journal, Endocrine disorders articles, Research on Breast cancer, Endocrine disorders



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
50
Articles published:
0
Comments:
23
Blog entries:
Get Updates
Get Updates
Abstract
Pay-per-view

A Review of the Structure, Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Insulin Glulisine in the Management of Diabetes Mellitus     (03/Jun/2010)


Glulisine (ApidraTM) is a rapid acting recombinant insulin analogue which differs from regular human insulin (RHI) by the substitution of lysine for asparagine at position B3 and glutamic acid for lysine at position B29. The chemical name is 3B-Lys-29- B-Glu-human insulin. The amino acid substitutions of glulisine and other rapid...


Abstract
Pay-per-view

Pioglitazone-Metformin Extended-Release Fixed-Dose Combination for the Treatment of Type 2 Diabetes     (17/May/2010)


Background: Combination oral glucose-lowering drug therapy is often required to maintain glycemic control in patients with type 2 diabetes. Single-tablet fixed-dose combinations of oral glucose-lowering agents provide one means to increase adherence, which may improve metabolic and clinical outcomes. A new fixed-dose combination of pioglitazone and extended-release metformin has recently...


Abstract
Full-text PDF

Elevated Serum Sorbitol and not Fructose in Type 2 Diabetic Patients     (04/May/2010)


Reductions in fasting serum fructose or erythrocyte sorbitol have been proposed as markers for early proof of mechanism in clinical development of aldose reductase (AR) inhibitors. However fructose is significantly impacted by meals and evaluation of erythrocyte sorbitol poses technical challenges. To more accurately assess the performance of these markers...


Abstract
Full-text PDF

The Common FTO Genetic Polymorphism rs9939609 is Associated with Increased BMI in Type 1 Diabetes  but not with Diabetic Nephropathy     (27/Apr/2010)


The fat mass and obesity associated (FTO) gene has an important genetic effect on body mass index (BMI) and risk of obesity, and obesity contributes to the progression of renal diseases, including diabetic nephropathy. We thus conducted a genetic association study to evaluate whether the FTO gene confers the...


Abstract
Pay-per-view

Saxagliptin a New Second Line Therapy After Metformin for the Treatment of Type 2 Diabetes     (27/Apr/2010)


Type 2 diabetes mellitus (T2DM) is a major public health problem that affects an increasingly larger number of individuals worldwide. Metformin, unless contraindicated, is the recommended first line pharmacological treatment as it can achieve good glycemic control without weight gain or hypoglycemia and with evidence for cardioprotection. T2DM is a...


Abstract
Full-text PDF

Parathyroid Hormone’s Acute Effect on Vasodilatory Function     (26/Apr/2010)


Parathyroid hormone (PTH) seems to affect the risk of cardiovascular disease. The aim of the present study was to investigate PTH’s acute effect on endothelial vasodilatory function in forearm resistance vessels. Ten healthy subjects underwent forearm venous occlusion plethysmography. We measured forearm blood flow at baseline and at a stable,...


Abstract
Full-text PDF

Higher Dietary Protein Intake is Associated with Lower Body Fat in the Newfoundland Population     (31/Mar/2010)


Background: Increased protein proportions in the diet combined with energy restriction has been shown to enhance weight loss during dietary intervention. It is not known if the beneficial effect of dietary protein exists in the general population under normal living conditions without a negative energy balance. Methods: A total...


Abstract
Full-text PDF

The Old and the New in the Treatment of Type 2 Diabetes: Focus on the Combination Therapy with Dipeptidyl Peptidase-4 Inhibitors and Metformin     (30/Mar/2010)


Type 2 diabetes mellitus (T2DM) is a complex multifactorial disease which affects the length and quality of life by severe chronic complications. Chronic hyperglycemia, which is the main alteration in T2DM, is strictly related to microvascular complications (such as retinopathy and nephropathy) and neuropathy, whereas large vessel atherosclerosis is also...


Abstract
Full-text PDF

Pegaptanib Sodium in the Treatment of Neovascular Age-Related Macular Degeneration     (29/Mar/2010)


Pegaptanib sodium is a polyethylene-glycolated, 28-nucleotide RNA aptamer that binds selectively to vascular endothelial growth factor (VEGF)165 but not smaller isoforms. Preclinical studies identified VEGF165 as an especially potent promoter of ocular neo-vascularization and inflammation. Following the pivotal clinical trials demonstrating the efficacy of intravitreal pegaptanib in treating all angiographic...


Abstract
Full-text PDF

A Practical Guide to Treatment with Liraglutide     (26/Mar/2010)


Liraglutide—a once-daily human glucagon-like peptide-1 receptor agonist for treatment of Type 2 diabetes—provides effective glycemic control with a lower incidence of hypoglycemia than therapies such as glimepiride and exenatide, and reduces body weight and systolic blood pressure. This article briefly discusses efficacy and safety results from the Liraglutide Effect and...


Abstract
Full-text PDF

An Investigation of Hair Cortisol Concentration Across Body Sites and within Hair Shaft     (11/Mar/2010)


Cortisol concentrations in hair collected from young male and female adults were assayed and compared for differences along shaft length and between body sites. No significant differences were found between hair shaft sites, supporting a model of the hair shaft as “alive” and responsive to environmental demand in terms of...


Abstract
Full-text PDF

Diurnal Variation in Peripheral (Hair) vs Central (Saliva) HPA Axis Cortisol Concentrations     (08/Mar/2010)


Cortisol concentrations in hair and saliva collected from male and female adults over a 15-hour period were compared for differences in overall level and cyclic pattern. Typical diurnal fluctuations were noted for both salivary and hair cortisol, with some individual differences that are congruent with the previous literature. Issues of...


Abstract
Full-text PDF

Metabolic Implications of Hepatitis C Virus Infection and it’s Correlation to Steatohepatitis in Chronic Hepatitis C Patients With and Without Type 2 Diabetes     (02/Mar/2010)


Background: Chronic hepatitis C virus (HCV) infection is not a simple viral infection; it has many metabolic and autoimmune complications. Objective: To investigate the impacts of chronic HCV infection on glucose and lipid metabolism and its correlation-if any-with body mass index (BMI) and hepatosteatosis in chronic HCV patients. Patients and Methods: One...


Abstract
Pay-per-view

Current and Emerging Therapies in Hypercholesterolemia: Focus on Colesevelam     (17/Feb/2010)


Background: Statins are recommended as first line therapy for the prevention of cardiovascular disease. Some individuals are statin intolerant or may need additional cholesterol lowering to achieve their cholesterol targets. Purpose: To review the pharmacology, clinical efficacy and safety of colesevelam mono- and combination therapy in patients with hypercholesterolemia. Data source: English-language...


Abstract
Pay-per-view

Pramlintide in the Management of Obesity     (17/Feb/2010)


Obesity is a common problem that can lead to numerous comorbid conditions, including Type 2 diabetes. Currently, there are few pharmacologic options available to help obese patients lose weight. Pramlintide is an injectable, amylin analogue that is indicated in patients with Type 1 and Type 2 diabetes for use...


Abstract
Full-text PDF

Introductory Editorial     (10/Feb/2010)


Introductory Editorial by Dr Karna Dev Bardhan


Abstract
Full-text PDF

Brief Alcohol Intervention Among At-Risk Drinkers with Diabetes     (09/Feb/2010)


Twenty-eight patients with diabetes who screened positive for at-risk drinking were assigned to brief alcohol intervention (BAI) (n = 14) or standard care (SC) (n = 14) treatment conditions. All participants completed a baseline interview and one-, three, and six-month follow-up interviews. Across the six-month follow-up period, there was a...


Abstract
Pay-per-view

Liraglutide: A Review of its Use in the Treatment of Diabetes Mellitus     (04/Feb/2010)


Among the new therapeutic options for type 2 diabetes care, the incretin-based treatments are considered particularly promising. Two classes of drugs have been developed, GLP-1 receptor agonists and DPP-IV inhibitors, that respectively mimic or prolong the action of the human GLP-1, key-hormone in the glucose homeostasis maintenance. Liraglutide is a GLP-1...


Abstract
Full-text PDF

A Pain-free Lancet with a Small Needle for Glucose Measurement     (28/Jan/2010)


A new lancet with an extremely small needle (0.15 mm diameter and 0.75 mm length) mounted on a small pedestal was tested in diabetic patients for blood glucose measurement in a randomized clinical study. A total of 37 diabetic patients were enrolled for the study. A pain scale categorized from...


Abstract
Full-text PDF

Chronic Complications of Diabetes in Iraq: Experience  from Southern Iraq     (21/Jan/2010)


Background: The aim of this study is to evaluate the prevalence of chronic complications in type 2 diabetic patients in Basrah (Southern Iraq). Methods: This was a longitudinal descriptive study for patients with diabetes registered in Al-Faiha Diabetes and Endocrine Centre in Basrah (Southern Iraq) for the period from...


Abstract
Full-text PDF

Insulin Resistance, Type 2 Diabetes and Chronic Liver Disease. A Deadly Trio     (20/Jan/2010)


In this commentary to the paper by Donadon V. et al (Clinical Medicine: Endocrinology and Diabetes. 2009;2:25–33.) the association and significance of insulin resistance with chronic liver disease are shortly reviewed and the molecular mechanisms underlying the diabetogenic and oncogenic potentials of advanced liver disease are summarized. Literature studies demonstrate...


Abstract
Pay-per-view

Management Strategies for Type 2 Diabetes: Focus on Vildagliptin     (20/Jan/2010)


The antidiabetic effect of the dipeptidyl peptidase 4 (DPP-4) inhibitors depends on the prolongation of action of the 2 incretin hormones: glucagon like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) by preventing their rapid degradation by the enzyme DPP-4. The use of the DPP-4 inhibitor vildagliptin is associated with mean...


Abstract
Full-text PDF

Gender-associated Differences in Weight Gain, Insulin Requirement and Metabolic Control in Newly Insulin-treated Type 2 Diabetic Patients with Secondary Sulfonylurea  Failure—a One-year Observation     (13/Jan/2010)


Objective: The aim of the present study was to determine differences between male and female type 2 diabetic patients concerning body weight, metabolic control, insulin requirement and prevalence of vascular diseases during the first year insulin therapy. Patients and Methods: We investigated 102 newly insulin-treated type 2 diabetic patients (60 female)...


Abstract
Full-text PDF

Insulin Resistance—a Link Between Inflammation and Hepatocarcinogenesis?     (11/Dec/2009)


The incidence of hepatocellular carcinoma (HCC) is increasing world wide. The risk factors for the development of HCC include liver cirrhosis, chronic alcohol intake, and chronic viral hepatitis. These conditions are associated with inflammation, liver cell injury, and oxidative stress. The signaling pathways that contribute to liver cell injury have...


Abstract
Full-text PDF

Is Glycogen Synthase Kinase-3β an Ultraconserved Kernel Enzyme?     (11/Dec/2009)


Glycogen synthase kinase 3β (GSK3β) was discovered as a major factor in glucose homeostasis. GSK3β is a pivotal regulator of glycogen synthesis by altering the activity of glycogen synthase and perturbation in this process have been linked to at least some sub-entities of insulin resistance and diabetes mellitus. However, GSK3β...


Abstract
Full-text PDF

Common Variable Immunodeficiency Associated with Inflammatory Bowel Disease and Type I Diabetes     (27/Nov/2009)


Common variable immunodeficiency (CVID) is a heterogeneous group of primary immunodeficiency disorders characterized by defective antibody production, low levels of serum immunoglobulins and increased susceptibility to infection. The patient was a 39-year-old male who was admitted to the gastroenterology department with a two week history of diarrhea, blunt abdominal pain...


Abstract
Full-text PDF

Retinal Ganglion Cell Loss in Diabetes Associated with Elevated Homocysteine     (17/Nov/2009)


A number of studies have suggested that homocysteine may be a contributing factor to development of retinopathy in diabetic patients based on observed correlations between elevated homocysteine levels and the presence of retinopathy. The significance of such a correlation remains to be determined, and potential mechanisms by which homocysteine might...


Abstract
Full-text PDF

The Impact of Obesity on Adverse Cardiovascular Outcomes in the General Population and in Patients with Type 2 Diabetes     (28/Oct/2009)


Objectives: There is an established causal link between obesity and cardiovascular outcomes. The aim of this review was to determine whether an independent relationship exists between anthropometric measurements of weight (typically body mass index [BMI]) and cardiovascular outcomes (e.g. angina, myocardial infarction, congestive heart failure, stroke, and mortality due to...


Abstract
Full-text PDF

Intestinal Obstruction and Pheochromocytoma in a Patient Suffering from von Recklinghausen’s Disease     (13/Oct/2009)


GISTs are rare neoplasms, which were recently identified to be a distinct pathologic entity. They can develop in patients with neurofibromatosis type 1 (NF1) or may be sporadic. NF1 is one of the most common inherited diseases and is a complex disease, with patients having an increased prevalence of benign...


Abstract
Full-text PDF

Metformin: A Review of its Use in the Treatment of Type 2 Diabetes     (25/Sep/2009)


Metformin is now the most widely prescribed oral hypoglycemic agent. This review outlines its use in the treatment of type 2 diabetes. The main mechanisms of action include reduction of appetite and of intestinal carbohydrate absorption, inhibition of hepatic gluconeogenesis, and increased glucose uptake by peripheral tissues. Metformin has been...